Reparexin is a noncompetitive allosteric inhibitor of the IL-8 receptors CXCR1 and CXCR2, and its cytotoxic effects on cancer cells at different concentrations were not significantly different (Supplementary Fig. 5A). The gene discussed is CXCR1; the disease is cancer.